Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 mAb that is in Phase 1b/2 clinical trials for the treatment advanced solid tumors and non-Hodgkin's lymphoma.
| Market Cap | 58.823 Million | Shares Outstanding | 43.253 Million | Avg 30-day Volume | 9.321 Thousand |
| P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -1.48 |
| Price to Revenue | 7.7188 | Debt to Equity | 0.3342 | EBITDA | -77.747 Million |
| Price to Book Value | 0.8633 | Operating Margin | -903.0794999999999 | Enterprise Value | -44.264 Million |
| Current Ratio | 2.711 | EPS Growth | -0.014 | Quick Ratio | 2.621 |
| 1 Yr BETA | 0.5217 | 52-week High/Low | 2.84 / 0.9 | Profit Margin | -860.5856 |
| Operating Cash Flow Growth | -11.9708 | Altman Z-Score | -2.6684 | Free Cash Flow to Firm | -36.254 Million |
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | ||||||||||||||||
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|---|---|---|---|
| ADAGENE INC-ADR ADAG | 2023-06-07 22:15:04 UTC | -75.2392 | 80.3092 | 650000 |
| ADAGENE INC-ADR ADAG | 2023-06-07 21:45:05 UTC | -75.2392 | 80.3092 | 650000 |
| ADAGENE INC-ADR ADAG | 2023-06-07 21:15:04 UTC | -75.2392 | 80.3092 | 650000 |
| ADAGENE INC-ADR ADAG | 2023-06-07 20:45:04 UTC | -75.2392 | 80.3092 | 650000 |
| ADAGENE INC-ADR ADAG | 2023-06-07 20:15:06 UTC | -75.2392 | 80.3092 | 650000 |
| ADAGENE INC-ADR ADAG | 2023-06-07 19:45:04 UTC | -75.2392 | 80.3092 | 650000 |
| ADAGENE INC-ADR ADAG | 2023-06-07 19:15:04 UTC | -75.2392 | 80.3092 | 650000 |
| ADAGENE INC-ADR ADAG | 2023-06-07 18:45:04 UTC | -75.2392 | 80.3092 | 650000 |
| ADAGENE INC-ADR ADAG | 2023-06-07 18:15:03 UTC | -75.2392 | 80.3092 | 650000 |
| ADAGENE INC-ADR ADAG | 2023-06-07 17:45:05 UTC | -75.2392 | 80.3092 | 650000 |
| ADAGENE INC-ADR ADAG | 2023-06-07 17:15:04 UTC | -75.2392 | 80.3092 | 650000 |
| ADAGENE INC-ADR ADAG | 2023-06-07 16:45:03 UTC | -75.2392 | 80.3092 | 650000 |
| ADAGENE INC-ADR ADAG | 2023-06-07 16:15:04 UTC | -75.2392 | 80.3092 | 650000 |
| ADAGENE INC-ADR ADAG | 2023-06-07 15:45:04 UTC | -75.2392 | 80.3092 | 650000 |
| ADAGENE INC-ADR ADAG | 2023-06-07 15:15:04 UTC | -75.2392 | 80.3092 | 650000 |
| ADAGENE INC-ADR ADAG | 2023-06-07 14:45:04 UTC | -75.2392 | 80.3092 | 650000 |
| ADAGENE INC-ADR ADAG | 2023-06-07 14:15:03 UTC | -75.2392 | 80.3092 | 650000 |
| ADAGENE INC-ADR ADAG | 2023-06-07 13:45:03 UTC | -75.2392 | 80.3092 | 650000 |
| ADAGENE INC-ADR ADAG | 2023-06-07 13:15:04 UTC | -75.2392 | 80.3092 | 650000 |
| ADAGENE INC-ADR ADAG | 2023-06-07 12:45:04 UTC | -75.2392 | 80.3092 | 650000 |
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|
